SLPI and cholangiocarcinoma: Together, these pathways provide a mechanistic framework in which inflammation-induced SLPI primes cholangiocytes and CCA cells to proliferate, remodel the extracellular matrix via MMPs, and adopt VM-competent states that support perfusion independently of classical angiogenesis.